Status:
COMPLETED
Improving Implementation of Lung Cancer Screening in Diverse Populations II
Lead Sponsor:
University of Washington
Collaborating Sponsors:
American Lung Association
Conditions:
Early Detection of Cancer
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project assesses the feasibility, appropriateness, and acceptability of a "Commonly Asked Questions after Lung Cancer Screening" (CAQ) informational document that the investigators created, resul...
Detailed Description
Barriers to optimal implementation of lung cancer screening (LCS) include low levels of patient knowledge. Patient understanding of LCS results may alleviate distress and improve understanding of reco...
Eligibility Criteria
Inclusion
- Has undergone LCS or is referred for LCS
- Able to give informed consent
Exclusion
- Cognitive or language limitations (i.e., expressive language limitations, non-English speaking
- Known malignancy other than non-melanoma skin cancer
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT05265897
Start Date
December 1 2020
End Date
June 30 2021
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seattle Cancer Care Alliance
Seattle, Washington, United States, 98109